Gregory Demopulos
Chief Executive Officer bei OMEROS CORPORATION
Vermögen: 7 Mio $ am 31.03.2024
Profil
Gregory A.
Demopulos is the Chairman, President & Chief Executive Officer of Omeros Corp., a company he founded in 1994.
He is currently serving as a Director at Onconome, Inc., Tessera, Inc., Northwest NeuroNeighborhood, and Smead Funds Trust.
Dr. Demopulos has an undergraduate degree from Stanford University and a doctorate from Stanford University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OMEROS CORPORATION
3,22% | 31.12.2023 | 2 026 986 ( 3,22% ) | 7 Mio $ | 31.03.2024 |
Aktive Positionen von Gregory Demopulos
| Unternehmen | Position | Beginn |
|---|---|---|
| OMEROS CORPORATION | Chief Executive Officer | 16.06.1994 |
Tessera, Inc.
 Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Director/Board Member | - |
Onconome, Inc.
 Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Director/Board Member | - |
| Smead Funds Trust | Director/Board Member | - |
| Northwest NeuroNeighborhood | Director/Board Member | - |
Ausbildung von Gregory Demopulos
| Stanford University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Health Technology |
| Smead Funds Trust | Miscellaneous |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Electronic Technology |
| Northwest NeuroNeighborhood |
